You are here: Industry Insights > Mundipharma

News List

Mundipharma people focus acknowledged by industry awards pharmaasia
August 18, 2017
Mundipharma scoops four awards at Employer Branding Institute Awards, including Best Company.
Mundipharma agrees $250m ‘smart chemotherapy’ deal pharmafile
August 16, 2017
A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits of their labour, with Mundipharma swooping to take CAP7.I into Phase 3 trials.
Mundipharma China Expands Consumer Health Portfolio with Kleenex Family Mask Range Supported by a Ne biospectrumasia
July 26, 2017
The app is the latest in a series of digital initiatives Mundipharma has developed to deliver improved healthcare outcomes.
Mundipharma becomes "Official Healthcare Product Partner" of Yokohama F. Marinos en-cphi.cn
July 11, 2017
Mundipharma K. K. (headquarters: Minato-ku, Tokyo; President, Shosuke Kimura) today announced that Mundipharma has signed a partnership with J League club Yokohama F. Marinos to be their "Official Healthcare Product Partner."
Mundipharma launches hygiene products in Thailand biospectrumasia
July 06, 2017
The new products are free from ingredients such as SLS (Sodium Lauryl Sulfate), MIT (Methylisothiazolinone), Parabens, and Triclosan that are commonly found in personal care products.
Mundipharma’s CEO ranked among Pharma business captains pharmaasia
May 31, 2017
Mundipharma’s Raman Singh ranked among world’s leading pharma business captains.
Mundipharma's Raman Singh Ranked Among World's Leading Pharma Business Captains en-cphi.cn
May 11, 2017
Raman Singh, Mundipharma's CEO has been ranked seventh most prominent Business Captain among a list of the top 100 pharmaceutical sector leaders by UK-based industry publication, The Medicine Maker.
Mundipharma launches first augmented reality app ‘breatherite’ biospectrumasia
April 24, 2017
Breatherite delivers a personal experience by profiling patients based on their attitudes towards Asthma management.
Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy biospectrumasia
April 12, 2017
Invossa is an intra-articular injection that is non-surgical treatment option
Mundipharma’s Mundesine receives approval from Japan’s MHLW to treat PTCL pharmaceutical-technology
April 06, 2017
Mundipharma has secured regulatory approval of Mundesine (Forodesine hydrochloride) from Japan’s Ministry of Health, Labour and Welfare (MHLW) to treat relapsed / refractory Peripheral T-Cell Lymphoma (PTCL).

Previous page 1 2 3 4 5 6 Next page